REFERENCES
- Lin H.-Y., Rocher L.L., McQuillan M.A., Schmaltz S., Palella T.D., Fox I.H. Cyclosporine - Induced Hyperuricemia and Gout. N. Engl. J. Med. 1989; 321: 287–292
- Ahn K.J., Kim Y.S., Lee H.C., Park K., Huh K.B. Cyclosporine-Induced Hyperuricemia After Renal Transplant: Clinical Characteristics and Mechanisms. Transplant Proc. 1992; 4: 1391–1392
- Delaney V., Sumrani N., Daskalakis P., Hong J.H., Sommer B.G. Hyperuricemia and Gout in Renal Allograft Recipients. Transplant Proc. 1992; 24: 1773–1774
- Ben Hmida M., Hachicha J., Bahloul Z., Kaddour N., Kharrat M., Jarraya F., Jarraya A. Cyclosporine-Induced Hyperuricemia and Gout in Renal Transplants. Transplant Proc. 1995; 27: 2722–2724
- Gores P.F., Fryd D.S., Sutherland D.E., Najarian J.S., Simmons R.L. Hyperuricemia After Renal Transplantation. Am. J. Surg. 1998; 156: 397–400
- West C., Carpenter B.J., Hakala T.R. The Incidence of Gout n Renal Transplant Recipients. Am. J. Kidney Dis. 1987; 10: 369–372
- Kahan B.D., Flechner S.M., Lorber M.I., Golden D., Conley S., Van Curen C.T. Complications of Cyclosporine-Prednisone Immunosuppression in 402 Renal Allograft Recipients Exclusively Followed at a Single Center for From One to Five Years. Transplantation 1987; 43: 197–204
- Clive D.M. Renal Transplant–Associated Hyperuricemia and Gout. J. Am. Soc. Nephrology 2000; 11: 974–979
- Steidel K., Brandis M., Kramer M., Leititis J.U., Zimmerhackl L.B. Cyclosporine Inhibits Renal Uric Acid Transport in Renal Transplants Not in Children Treated for Nephritic Syndrome. Renal Failure 1990; 12: 193–198
- Cohen S.L., Boner G., Rosenfeld J.B., Shmueli D. The Mechanism of Hyperuricemia in Cyclosporine Treated Renal Transplant Recipients. Transplant Proc. 1987; 29: 1829–1830
- Hansen J.M., Fogh-Anderson N., Leyssac P.P., Strandgaard S. Glomerular and Tubular Function in Renal Transplant Patients Treated with and Without Cyclosporin A. Nephron 1998; 80: 450–457
- Marcén R., Gallego N., Orofuno L., Gamez C., Estepa M.R., Teruel J.L., Ortuño J. Impairment of Tubular Secretion of Urate in Renal Transplant Patients on Cyclosporine. Nephron 1995; 70: 307–313
- Hoyer P.F., Lee I.J., Oemar B.S., Krohn H.P., Offner G., Brodebi J. Renal Handling of Uric Acid Under Cycloporin A Treatment. Pediatr. Nephrol. 1998; 2: 18–21
- Zawadzki J., Grenda R., Januszewicz P. Effect of Nifedipine on Tubular Handling of Uric Acid in Transplanted Kidney on Cyclosporine A Treatment. Nephron 1995; 70: 77–82
- Laine J., Homberg C. Tubular Effects of Cyclosporine in Pediatric Renal Transplant Recipients. Transplant Proc. 1996; 28: 2104–2106
- Laine J., Holmberg C. Mechanisms of Hyperuricemia in Cyclosporine- Treated Renal Transplanted Children. Nephron 1996; 74: 313–323
- Braun W.E., Richmond B.J., Protiva D.A., Gifford W.A., Strabbon R.A. The Incidence and Management of Osteoporosis, Gout and Avascular Necrosis in Recipients of Renal Allografts Functioning More Than 20 Years Treated with Prednisone and Azathioprim. Transplant Proc. 1999; 31: 1366–1369
- Evardsson V.O., Kaiser B.A., Polinsky M.J., Plamer J., Quiem R., Baluarte H.J. Natural History and Etiology of Hyperuricemia Following Pediatric Renal Transplantation. Pediatr. Nephrol. 1995; 9: 57–60
- Noordzij T.C., Leunissen K.M.L., Van Hooff J. Renal Handling of Urate and the Incidence of Gouty Arthritis During Cyclosporine and Diuretic Use. Transplantation 1991; 52: 64–67
- Kahl L., Thompson M.E., Griffith B.P. Gout in the Heart Transplant Recipient: Physiologic Puzzle and Therapeutic Challenge. Am. J. Med. 1989; 87: 289–294
- Palestine A.G., Nussenblatt R.S., Chanc C. Side Effects of Systemic Cyclosporine in Patients Not Undergoing Transplantation. Am. J. Med. 1984; 77: 652–656